Literature DB >> 29746871

Discrete typing units of Trypanosoma cruzi detected by real-time PCR in Chilean patients with chronic Chagas cardiomyopathy.

Catalina Muñoz-San Martín1, Inés Zulantay1, Miguel Saavedra1, Cristián Fuentealba1, Gabriela Muñoz1, Werner Apt2.   

Abstract

Chagas disease is a major public health problem in Latin America and has spread to other countries due to immigration of infected persons. 10-30% of patients with chronic Chagas disease will develop cardiomyopathy. Chagas cardiomyopathy is the worst form of the disease, due to its high morbidity and mortality. Because of its prognostic value and adequate medical monitoring, it is very important to identify infected people who could develop Chagas cardiomyopathy. The aim of this study was to determine if discrete typing units (DTUs) of Trypanosoma cruzi are related to the presence of heart disease in patients with chronic Chagas disease. A total of 86 untreated patients, 41 with cardiomyopathy and 45 without heart involvement were submitted to clinical study. Electrocardiograms and echocardiograms were performed on the group of cardiopaths, in which all important known causes of cardiomyopathy were discarded. Sinus bradycardia and prolonged QTc interval were the most frequent electrocardiographic alterations and patients were classified in group I (46%) and group II (54%) of New York Hearth Association. In all cases real-time PCR genotyping assays were performed. In the group with cardiomyopathy, the most frequent DTU was TcI (56.1%), followed by TcII (19.5%). Mixed infections TcI + TcII were observed in 7.3% of the patients. In the group without cardiac pathologies, TcI and TcII were found at similar rates (28.9 and 31.1%, respectively) and mixed infections TcI + TcII in 17.8% of the cases. TcIII and TcIV were not detected in any sample. Taken together, our data indicate that chronic Chagas cardiomyopathy in Chile can be caused by strains belonging to TcI and TcII.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cardiomyopathy; Chagas disease; DTU; Genotyping; qPCR

Mesh:

Year:  2018        PMID: 29746871     DOI: 10.1016/j.actatropica.2018.05.004

Source DB:  PubMed          Journal:  Acta Trop        ISSN: 0001-706X            Impact factor:   3.112


  4 in total

1.  Disease Tolerance and Pathogen Resistance Genes May Underlie Trypanosoma cruzi Persistence and Differential Progression to Chagas Disease Cardiomyopathy.

Authors:  Christophe Chevillard; João Paulo Silva Nunes; Amanda Farage Frade; Rafael Ribeiro Almeida; Ramendra Pati Pandey; Marilda Savóia Nascimento; Jorge Kalil; Edecio Cunha-Neto
Journal:  Front Immunol       Date:  2018-12-03       Impact factor: 7.561

2.  Association between Trypanosoma cruzi DTU TcII and chronic Chagas disease clinical presentation and outcome in an urban cohort in Brazil.

Authors:  Marco Antonio Prates Nielebock; Otacílio C Moreira; Samanta Cristina das Chagas Xavier; Luciana de Freitas Campos Miranda; Ana Carolina Bastos de Lima; Thayanne Oliveira de Jesus Sales Pereira; Alejandro Marcel Hasslocher-Moreno; Constança Britto; Luiz Henrique Conde Sangenis; Roberto Magalhães Saraiva
Journal:  PLoS One       Date:  2020-12-02       Impact factor: 3.240

3.  Parasite load evaluation by qPCR and blood culture in Chagas disease and HIV co-infected patients under antiretroviral therapy.

Authors:  Gláucia Elisete Barbosa Marcon; Juliana de Jesus Guimarães Ferreira; Eros Antonio de Almeida; Adriane Maira Delicio; Mariane Barroso Pereira; Jamiro da Silva Wanderley; Luiz Cláudio Martins; Paula Durante Andrade; Rodrigo Gonçalves de Lima; Sandra Cecília Botelho Costa
Journal:  PLoS Negl Trop Dis       Date:  2022-03-30

4.  Discrete Typing Units of Trypanosoma cruzi Identified by Real-Time PCR in Peripheral Blood and Dejections of Triatoma infestans Used in Xenodiagnosis Descriptive Study.

Authors:  Inés Zulantay; Gabriela Muñoz; Daniela Liempi; Tamara Rozas; María José Manneschi; Catalina Muñoz-San Martín; Carezza Botto-Mahan; Werner Apt; Gonzalo Cabrera
Journal:  Pathogens       Date:  2022-07-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.